ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2026
SARS-CoV-2 lineage-specific disease symptoms and disease severity in a city in southeastern Brazil.
Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2020, Sao Caetano do Sul city, located in the metropolitan region of Sao Paulo State, Brazil, established a web-based platform to provide primary care to suspected COVID-19 patients, integrating clinical and demographic data and sample metadata. Here we describe lineage-specific spatiotemporal dynamics of infections, clinical symptoms, and disease severity during the first year of the epidemic, which included circulation of the poorly characterised Gamma variant of concern. From April 6, 2020, to April 30, 2021, we gathered clinical, demographic, spatial and epidemiological data from the city's platform. We selected and sequenced 879 PCR+ swab samples (8% of all reported cases), obtaining a spatially and temporally representative set of sequences. Daily lineage-specific prevalence was estimated with a moving-window approach, allowing inference of cumulative cases and symptom probability stratified by lineage using integrated data from the platform. Most infections were caused by B.1.1.28 (41.3%), followed by Gamma (31.7%), Zeta (9.6%), and B1.1.33 (9.0%). Gamma and Zeta correlated with larger prevalence of dyspnoea (respectively, 81.3% and 78.5%) and persistent fever (84.7% and 61.1%) compared with B.1.1.28 and B.1.1.33. Ageusia, anosmia, and coryza were respectively 18.9%, 20.3%, and 17.8% less commonly caused by Gamma, whereas altered mental status was 108.9% more common in Zeta. Case incidence was spatially heterogeneous and larger in poorer and younger districts. Our study reveals that Gamma was associated with more severe presentation of the disease, emphasising its role in the heightened mortality levels in Brazil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.